Gabexate mesilate, a new synthetic serine protease inhibitor: A pilot clinical trial in valvular heart surgery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 10, Issue 2, 1996, Pages 235-237

  Parodi, F ^a   Cordero, G ^a   De Gasperis, C ^a   Minola, P ^a   Dellora, C ^a   Innocenti, P ^a  

^a MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

Author keywords

blood saver; cardiac surgery; gabexate mesilate (Foy); transfusion

Indexed keywords

GABEXATE MESILATE; HEPARIN;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; HEART VALVE REPLACEMENT; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

EID: 0030003851     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(96)80244-8     Document Type: Article

References (14)

1. Watel A Mathieu D Pol A Modifications hematologiques induites pour la circulation extracorporelle Ann Fr Anesth Reanim 4 1985 360 366
2. Hunt BJ Yacoub M Aprotinin and cardiac surgery BMJ 303 1991 660 661
3. Gaus H Subramaman V John S Theoretical and practical (clinical) considerations concerning proteolytic enzymes and their inhibitors with particular reference to changes in the plasminogen-plasmin system observed during assisted circulation in man Ann NY Acad Sci 146 1968 721 736
4. Orbau AE Brecher AM Popov-Cenic'S Blutungen nach intrakardialen operativen Eingriffen in Sauglingsalter: Klinische relevanz und perioperative Therapie Blumel G Haas S Mikrozirkulation und Prostaglandin Stoffewechsel 1981 Schattaner Stuttgart, Germany 275 278
5. Royston D Taylor KM Bidstrup BP Effect of aprotinin on need for blood transfusion after repeat open heart surgery Lancet 2 1987 1289 1291
6. Van Oeveren W Jansen NJG Bidstrup BP Effects of aprotinin on haemostatic mechanism during cardiopulmonary bypass Ann Thorac Surg 44 1987 640 645
7. Fraedrich G Weber C Bernard C Reduction of blood transfusion requirement in open heart surgery by administration of high doses of aprotinine—Preliminary results Thorac Cardiac Surg 37 1989 89 91
8. Covino E Pepino D Iorio Low dose aprotinin as blood saver in gen heart surgery Eur J Cardiothorac Surg 5 1991 414 418
9. Royston D Aprotinin to prevent bleeding: The first 5 years J Cardiothorac Vasc Anesth 6 1992 76 100
10. Ohno H Kosaki G Kambayashi J Foy: methane sulfonate as a serine proteinase inhibitor. Inhibition of thrombin and factor Xa in vitro Thromb Res 19 1980 579 589
11. Pederzoli P Cavallini G Falconi M Gabexate Mesilate versus Aprotinin in human acute pancreatitis (GA.ME.PA.) Int J Pancreatol 14 1993 117 124
12. Taenaka N Shimada Y Hirata T Gabexate Mesilate (FOY) therapy of disseminated intravascular coagulation due to sepsis Crit Care Med 11 1983 735 738
13. Youngberg JA Aprotinin and thrombus formation on pulmonary artery catheters: A piece of the coagulation puzzle J Cardiothorac Anesth 4 1990 155 158
14. Daviers RJ Lane DA Mc Gregor IR The neutralization of heparin by Trasylol Thrombosis Res 17 1980 533 537